Isquaemia Biotech, a company owned by Canaan Reserch & Investment, an investment company specializing in the biotechnology sector, together with the Autonomous University of Madrid and the Higher Council of Scientific Research have signed a license agreement for the development of a cutaneous regeneration procedure.
The invention has been developed by researchers from the Department of Biology of the University and the Institute of Biomedical Research “Alberto Sols” (IIBM), mixed center UAM-CSIC.
Cutaneous regeneration occurs thanks to a limited and transient production of ROS (reactive oxygen species) in the tissue. According to the researchers, an excessive accumulation of these oxidizing compounds in the body is associated with different diseases and the aging process. However, a locally limited production in the cell, activates and regulates essential physiological functions such as proliferation, differentiation or motility.
In this context, the procedure has proved extremely effective in stimulating cutaneous regeneration and homeostasis in experimental mouse models, accelerating physiological processes such as the healing of burns and wounds as well as hair growth. Currently, its effectiveness in human skin is being tested, obtaining very promising results.
In the development of this technology, doctors Jesús Espada, Elisa Carrasco, Ángeles Juarranz, María Inmaculada Calvo and Alfonso Blázquez participated.
Read more: http://fuam.es/isquaemia-biotech-licencia-una-tecnologia-de-la-uam-y-el-csic-para-la-regeneracion-cutanea/